Literature DB >> 8896112

High-resolution MR imaging of the breast.

S G Orel1.   

Abstract

Investigation into the use of MRI as a breast imaging tool is ongoing. Several studies have shown that MRI is a very accurate imaging method for the identification of implant failure in the symptomatic patient with augmented breasts. In this clinical setting. MRI may be the study of choice. Imaging techniques, and the MRI appearance of normal and abnormal implants, are described. The use of MRI for the detection of breast cancer is not as straightforward. Preliminary results suggest that this technique can be used as an adjunct to mammography for the detection and diagnosis of breast cancer. However, it is premature to draw firm conclusions regarding the role that MRI should play in the management of women with breast disease because of the wide variability of imaging techniques, protocols, and patient populations in the studies reported to date. In this overview, the current state of MR imaging of the breast is discussed. Technical requirements are described, and potential clinical applications- including the differentiation of benign from malignant lesions, breast cancer staging, detection of recurrence after breast conservation therapy, and detection of cancer in patients presenting with positive axillary lymph nodes with an unknown primary-are reviewed. Many of these potential clinical applications will require an accurate MR-guided biopsy system, and the implementation of such a system as well as its inherent limitations are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8896112     DOI: 10.1016/s0887-2171(96)90032-3

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  2 in total

1.  Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.

Authors:  Allison W Kurian; Anne-Renee Hartman; Meredith A Mills; James M Ford; Bruce L Daniel; Sylvia K Plevritis
Journal:  Health Expect       Date:  2005-09       Impact factor: 3.377

2.  Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy.

Authors:  P Viehweg; A Heinig; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.